MRI-derived IVIM-modelled diffusion-weighted imaging does not predict clinical outcomes in fontan-associated liver disease: to monitor or not to monitor the liver? - Poll - MDSpire

MRI-derived IVIM-modelled diffusion-weighted imaging does not predict clinical outcomes in fontan-associated liver disease: to monitor or not to monitor the liver?

  • By

  • Gaston van Hassel

  • Frans J. C. Cuperus

  • Paul E. Sijens

  • Tineke P. Willems

  • Eryn T. Liem

  • Elke S. Hoendermis

  • Joost P. van Melle

  • Rolf M. F. Berger

  • June 22, 2026

  • 0 min

Share

Original Source(s)

MRI-derived IVIM-modelled diffusion-weighted imaging does not predict clinical outcomes in fontan-associated liver disease: to monitor or not to monitor the liver?

  • by Gaston van Hassel, Frans J. C. Cuperus, Paul E. Sijens, Tineke P. Willems, Eryn T. Liem, Elke S. Hoendermis, Joost P. van Melle, Rolf M. F. Berger

  • June 22, 2026

Related Content

The longstanding issue of the benefit of ursodeoxycholic acid in primary sclerosing cholangitis: a long-term population-based study

Case Report: Successful treatment of pyoderma gangrenosum-like granulomatous liver disease without skin lesions using a TNF-alpha inhibitor

Nurr1 deficiency orchestrates a coupled liver–gut pathological axis revealed by multi-omics and deep-learning histopathology